Shopping for GSK, becoming Allergan, and turning $5M into $315M
Released: Jun 22, 2015
Fierce editors discuss the news of the week, including rumors surrounding GlaxoSmithKline, the evolution of Allergan and a big-money IPO that is spooking some biotech watchers.
